Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02955121 · ClinicalTrials.gov registry record · NA
IU Health Krannert Personalized Medicine Study
A NA study, sponsored by Indiana University.
- Terminated
- Registry status
- NA
- Development phase
- 107
- Enrollment target
NCT02955121: Clinical Trial NA study, sponsored by Indiana University.
NCT02955121 is a NA study that was terminated before completion, run by Indiana University. The registered enrollment target is 107 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02955121, a NA study, was terminated before completion, sponsored by Indiana University.
- TERMINATED
- Registry status
- NA
- Development phase
- 107 participants
- Enrollment target
Study Summary
Randomized controlled study to examine physician use of pharmacogenetic information in patients receiving antiplatelet medication after percutaneous coronary intervention (PCI).
Primary Outcome
Number of individuals whose initial P2Y12 inhibitor therapy was changed to another P2Y12 inhibitor during time of follow up
Interventions
- OTHER Prescriber Access to Genetic Information
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2016-11 |
| Est. Completion | 2020-01-15 |
| Phase | NA |
Why NCT02955121 stopped before completion
NCT02955121 is an interventional study that assigns participants to a tested intervention. The registered 107 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 1 intervention - of which Prescriber Access to Genetic Information is the first listed.
NCT02955121 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02955121 about?
NCT02955121 is a clinical study titled "IU Health Krannert Personalized Medicine Study". Randomized controlled study to examine physician use of pharmacogenetic information in patients receiving antiplatelet medication after percutaneous coronary intervention (PCI).
What is the current status of trial NCT02955121?
This trial is currently terminated. It is a NA study. The enrollment target is 107 participants. The study started on 2016-11. Estimated completion is 2020-01-15.
What interventions are being tested in trial NCT02955121?
The interventions under investigation include: Prescriber Access to Genetic Information (OTHER).
Who is sponsoring clinical trial NCT02955121?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02955121's enrollment target sits among peer trials
107 830th of 2000 higher than 1,171 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05491668 · 107 participants
Physiological Assessment of Severe Coronary Stenosis for Informing Planned PCI
- NCT06041594 · 107 participants · NA
Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)
- NCT06081426 · 107 participants · NA
Examining Neurobiological Mechanisms Underlying the Therapeutic Effect of the Ketogenic Diet in Bipolar Disorder (BD)
- NCT06527599 · 107 participants · NA
Screening in Trauma for Opioid Misuse Prevention - an Adaptive Intervention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia